Yes but were talking about monies paid by SMI to GTHP that were then owed to Shenghuo.
But again, I don't care about China or your claims against Faupel and Blumberg. I only care about the clinical trials being completed, the FDA submission, and FDA approval. I believe the FDA will approve the application THIS TIME.
IF GTHP gets any money from SMI, that would be icing on the cake. I don't think SMI has that kind of money. But IF the doctors who ran that study publish their results, that is a huge win for GTHP because they could then submit that study with their US study.
News 
Market Data 
Discover 
